ETOP IBCSG Partners Foundation

As of July 1, 2021, the two highly respected clinical and translational cancer research foundations ETOP (European Thoracic Oncology Platform) and IBCSG (International Breast Cancer Study Group) have merged to form the joint entity ETOP IBCSG Partners Foundation. The new foundation brings together two strong and equal partners. By joining forces, the position as an international academic research organization is further strengthened www.etop.ibcsg.org.

ETOP IBCSG Partners Foundation is a Swiss foundation governed by the ETOP IBCSG Partners Foundation Board. The Scientific Committee oversees the research agenda, and the Translational Research Working Group focuses on research involving collected tissue. All clinical trials are reviewed by an internal Ethics Committee. Interim and final results and safety reports from all ongoing clinical trials are reviewed semi-annually by the Independent Data Monitoring Committee (IDMC), an independent advisory group of expert oncologists, a statistician and a patient representative. ETOP IBCSG Partners Foundation is headquartered in Bern, Switzerland, with Statistical Center at Dana-Farber Cancer Institute, Boston, USA, Data Management Center at Frontier Science Foundation, Amherst, USA, and Central Pathology Review Office at the European Institute of Oncology, Milan, Italy.